iShares Neuroscience and Healthcare ETF (IBRN)
NYSEARCA: IBRN · Real-Time Price · USD
33.75
-0.19 (-0.56%)
At close: May 19, 2026, 4:00 PM EDT
33.75
0.00 (0.00%)
After-hours: May 19, 2026, 8:00 PM EDT
IBRN Holdings Information
IBRN is an equity ETF with a total of 84 individual holdings. The top holdings are Axsome Therapeutics stock at 4.93%, Xenon Pharmaceuticals at 4.62%, Alkermes at 4.61%, Arrowhead Pharmaceuticals at 4.59%, and Neurocrine Biosciences at 4.30%.
Total Holdings
84
Top 10 Percentage
42.52%
Asset Class
Equity
ETF Category
Health
Assets
5.23M
PE Ratio
16.48
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | AXSM | Axsome Therapeutics, Inc. | 4.93% |
| 2 | XENE | Xenon Pharmaceuticals Inc. | 4.62% |
| 3 | ALKS | Alkermes plc | 4.61% |
| 4 | ARWR | Arrowhead Pharmaceuticals, Inc. | 4.59% |
| 5 | NBIX | Neurocrine Biosciences, Inc. | 4.30% |
| 6 | PTCT | PTC Therapeutics, Inc. | 3.98% |
| 7 | ARGX | argenx SE | 3.94% |
| 8 | SRRK | Scholar Rock Holding Corporation | 3.90% |
| 9 | CNTA | Centessa Pharmaceuticals plc | 3.83% |
| 10 | PRAX | Praxis Precision Medicines, Inc. | 3.83% |
| 11 | BIIB | Biogen Inc. | 3.58% |
| 12 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.51% |
| 13 | ACAD | ACADIA Pharmaceuticals Inc. | 3.43% |
| 14 | DNTH | Dianthus Therapeutics, Inc. | 3.18% |
| 15 | SUPN | Supernus Pharmaceuticals, Inc. | 2.86% |
| 16 | DNLI | Denali Therapeutics Inc. | 2.82% |
| 17 | EWTX | Edgewise Therapeutics, Inc. | 2.68% |
| 18 | DYN | Dyne Therapeutics, Inc. | 2.38% |
| 19 | AXGN | Axogen, Inc. | 2.14% |
| 20 | KRX: 326030 | SK Biopharmaceuticals Co., Ltd. | 1.98% |
| 21 | SRPT | Sarepta Therapeutics, Inc. | 1.91% |
| 22 | HLUNB.CO | H. LUNDBECK CLASS B | 1.78% |
| 23 | CAPR | Capricor Therapeutics, Inc. | 1.50% |
| 24 | TSHA | Taysha Gene Therapies, Inc. | 1.45% |
| 25 | STO: BIOA.B | BioArctic AB (publ) | 1.31% |
As of May 14, 2026